The Tekniker technology centre is currently helping to develop a system to serve as an alternative to traditional toxicological analysis methods. The solution follows European Commission recommendatio...
Read moreIt has been developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30), which has shown high efficacy in patients with refractory CD30+ lymphoma
Read moreLa Fundación CRIS contra el cáncer ha otorgado dos becas de excelencia a investigadoras del Clínic Barcelona-IDIBAPS, con una dotación total de 680.000 euros.
Read moreThe targeted inhibitor ‘Zongertinib’ obtains positive responses in more than 70% of patients treated with this drug.
Read moreLos resultados de este estudio multicéntrico, denominado CYTOCOR y publicado recientemente enThe Lancet Regional Health Europe, han concluido que la estrategia inmunoguiada ofrece una eficacia compar...
Read moreRemote monitoring has become increasingly relevant in the digital era, especially following the COVID-19 pandemic, which brought about significant restrictions on travel and in-person contact. This ap...
Read moreToday, May 6th, is World Asthma Day, established thanks to the Global Initiative for Asthma (GINA) in 1998. The day's goal is to promote awareness of the disease, encourage the availability of effecti...
Read moreEl ensayo clínico para validar la primera vacuna del mundo contra esta alergia, liderado por la Clínica Universidad de Navarra y el Hospital Universitario de Navarra, cuenta con la aprobación de la...
Read moreA clinical trial led from Lleida has shown that the pre-hospital application of a technique called remote ischaemic conditioning can be a safe and promising strategy to improve recovery
Read moreThe new revision of the Good Clinical Practice (GCP) guideline—ICH E6 (R3)—introduces significant updates compared to its predecessor, E6 (R2). These changes are designed to reflect the evolving m...
Read moreEl Hospital de Bellvitge se ha sumado a uno de los estudios más grandes del mundo sobre inteligencia artificial (IA) aplicada a la prevención del cáncer de colon y recto. Se trata del proyecto ACCE...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the first quarter ended Marc...
Read more